Real-world study of Medtronic stroke treatment devices
Part of Brain & nervous system, Heart & circulation clinical trials.
This registry tracks how Medtronic's FDA-approved devices work in treating acute ischemic stroke (a type of stroke caused by a blood clot) in everyday clinical practice. Researchers collect information to understand device safety and effectiveness outside of formal clinical trials.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must be treated with a Medtronic Neurovascular device for acute ischemic stroke
- You must be able to complete follow-up visits as scheduled
- You must provide consent or have a legally authorized representative provide it
- You cannot be enrolled in other drug or device studies at the same time
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry study follows people who have already had a specific clot-removal procedure using the NeVa device. It helps doctors understand how the device performs in real-world care for certain kinds of stroke.
This study records outcomes for people having an acute ischemic stroke treated with an endovascular (catheter-based) procedure. It may help doctors understand how clot-removal treatment works in different patients and hospitals.
This study tests a new device called Ceretrieve that is designed to remove blood clots from large arteries in the brain for people having a severe ischemic stroke. If you are eligible, you will receive the device treatment (a mechanical thrombectomy) within 24 hours of your first symptoms.
This study collects information from routine medical care to learn how well MicroVention devices work in real-world settings for people being treated for brain aneurysms or stroke from a blocked artery. Your doctor has already decided to use one of these devices as part of your standard treatment.
This study follows patients who receive treatments for stroke or narrowing or bulging of brain blood vessels. It aims to see how well these treatments work in real life and if they are worth the cost.
This trial tests a medical device for treating acute ischemic stroke (a stroke caused by a blocked blood vessel in the brain). The device is used along with standard care to try to improve recovery and reduce disability.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.